<ARTICLE> 5 <LEGEND> This schedule contains summary information extracted from Intel Corporation's CONSOLIDATED CONDENSED STATEMENTS OF INCOME AND CONSOLIDATED BALANCE SHEETS and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-28-1996 <PERIOD-END> SEP-28-1996 <CASH> 3513 <SECURITIES> 2307 <RECEIVABLES> 3488<F3> <ALLOWANCES> 0 <INVENTORY> 1370 <CURRENT-ASSETS> 11215 <PP&E> 13621 <DEPRECIATION> 5363 <TOTAL-ASSETS> 21072 <CURRENT-LIABILITIES> 4006 <BONDS> 702 <PREFERRED-MANDATORY> 547<F1> <PREFERRED> 0 <COMMON> 2830 <OTHER-SE> 0 <TOTAL-LIABILITY-AND-EQUITY> 21072 <SALES> 14407 <TOTAL-REVENUES> 14407 <CGS> 6772 <TOTAL-COSTS> 6772 <OTHER-EXPENSES> 1288<F2> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 14 <INCOME-PRETAX> 4995 <INCOME-TAX> 1748 <INCOME-CONTINUING> 3247 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 3247 <EPS-PRIMARY> 3.67 <EPS-DILUTED> 0 <FN> <F1>Item consists of put warrants. <F2>Item consists of research and development. <F3>Item shown net of allowance, consistent with the balance sheet presentation. </FN>